| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.55 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.48 | 0.08 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.48 | 0.005 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.29 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.21 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |